U.S. FDA Moves to Smooth Path for Complex Generic Drugs U.S. FDA Moves to Smooth Path for Complex Generic Drugs

The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV ' s emergency EpiPen in an effort to address the rising cost of pharmaceuticals.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Pathology & Lab Medicine News Source Type: news